Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 423

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Drugs for treatment of very high blood pressure during pregnancy

Open access
Duley, Lelia, Meher, Shireen, Jones, Leanne · 2013 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Very high blood pressure during pregnancy poses a serious threat to women and their babies. The aim of antihypertensive therapy is to lower blood pressure quickly but safety, to avoid complications. Antihypertensive drugs lower blood pressure but their comparative effectiveness and safety, and impact on other substantive outcomes is uncertain. OBJECTIVES: To compare different antihypertensive drugs for very high blood pressure during pregnancy. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group Trials Register (9 January 2013). SELECTION CRITERIA: Studies were randomised trials. Participants were women with severe hypertension during pregnancy. Interventions were comparisons of one antihypertensive drug with another. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion and assessed trial quality. Two review authors extracted data and checked them for accuracy. MAIN RESULTS: Thirty-five trials (3573 women) with 15 comparisons were included. Women allocated calcium channel blockers were less likely to have persistent high blood pressure compared to those allocated hydralazine (six trials, 313 women; 8% versus 22%; risk ratio (RR) 0.37, 95% confidence interval (CI) 0.21 to 0.66). Ketanserin was associated with more persistent high blood pressure than hydralazine (three trials, 180 women; 27% versus 6%; RR 4.79, 95% CI 1.95 to 11.73), but fewer side-effects (three trials, 120 women; RR 0.32, 95% CI 0.19 to 0.53) and a lower risk of HELLP (haemolysis, elevated liver enzymes and lowered platelets) syndrome (one trial, 44 women; RR 0.20, 95% CI 0.05 to 0.81).Labetalol was associated with a lower risk of hypotension compared to diazoxide (one trial 90 women; RR 0.06, 95% CI 0.00 to 0.99) and a lower risk of caesarean section (RR 0.43, 95% CI 0.18 to 1.02), although both were borderline for statistical significance.Both nimodipine and magnesium sulphate were associated with a high incidence of persistent high blood pressure, but this risk was lower for nimodipine compared to magnesium sulphate (one trial, 1650 women; 47% versus 65%; RR 0.84, 95% CI 0.76 to 0.93). Nimodipine was associated with a lower risk of respiratory difficulties (RR 0.28, 95% CI 0.08 to 0.99), fewer side-effects (RR 0.68, 95% CI 0.55 to 0.85) and less postpartum haemorrhage (RR 0.41, 95% CI 0.18 to 0.92) than magnesium sulphate. Stillbirths and neonatal deaths were not reported.There are insufficient data for reliable conclusions about the comparative effects of any other drugs. AUTHORS' CONCLUSIONS: Until better evidence is available the choice of antihypertensive should depend on the clinician's experience and familiarity with a particular drug; on what is known about adverse effects; and on women's preferences. Exceptions are nimodipine, magnesium sulphate (although this is indicated for women who require an anticonvulsant for prevention or treatment of eclampsia), diazoxide and ketanserin, which are probably best avoided.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd001449.pub3

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 72 references

Research works printed but not linked: 95

  1. Hennessy, 2006, Parenteral intravenous optimal therapy trial - A RCT of hydralazine versus mini-bolus diazoxide for hypertensive crises in the obstetric setting [abstract], Hypertension in Pregnancy, 25, 22
  2. Martins-Costa, 1992, Randomized, controlled trial of hydralazine versus nifedpine in preeclamptic women with acute hypertension, Clinical and Experimental Hypertension, B11, 25
  3. Mesquita MR Attalah AN Camano L Bertini AM The use of hydralazine and nifedipine as treatment of hypertension emergency during pregnancy Proceedings of 2nd World Congress of Perinatal Medicine; 1993 September 19-24; Rome, Italy 1993 41 · doi:10.1016/0165-0378(93)90019-e
  4. Souza, 1994, Use of hydralazine and nifedipine in hypertensive emergency in pregnancy, Progresos de Obstetricia y Ginecologia, 37, 90
  5. de Souza Mesquita MR Atallah AN Bertini AM The use of hydralazine and nifedipine as treatment for hypertension emergency during pregnancy Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland 1994 163
  6. Moore, 1982, The treatment of hypertension in pregnancy, Current Medical Research and Opinion, 8, S39, 10.1185/03007998209110129 · doi:10.1185/03007998209110129
  7. Vizitiu, 2010, Urapidyl for hypertension control in severe pre-eclampsia: a comparative study with nicardipine, Critical Care, 14 Suppl 1, S48
  8. Schulz, 2001, Effect of urapidil in antihypertensive therapy of preeclampsia on newborns, Zentralblatt fur Gynakologie, 123, 529, 10.1055/s-2001-18226 · doi:10.1055/s-2001-18226
  9. Wacker, 1994, Treatment of patients with pre-eclampsia with urapidil, International Journal of Gynecology & Obstetrics, 46, 121
  10. Wacker J Christ M Muller J Grischke EM Bastert G Treatment of patients with pre-eclampsia with urapidil Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland 1994 186
  11. Wacker J Piel P Bastert G The treatment of pre-eclampsia with urapidil Proceedings of 10th World Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 185
  12. Wacker, 2006, Antihypertensive therapy in patients with pre-eclampsia: a prospective randomised multicentre study comparing dihydralazine with urapidil, European Journal of Obstetrics & Gynecology and Reproductive Biology, 127, 160, 10.1016/j.ejogrb.2005.09.013 · doi:10.1016/j.ejogrb.2005.09.013
  13. Aali, 2002, Nifedipine or hydralazine as a first-line agent to control hypertension in severe pre-eclampsia, Acta Obstetricia et Gynecologica Scandinavica, 81, 25, 10.1034/j.1600-0412.2002.810105.x · doi:10.1034/j.1600-0412.2002.810105.x
  14. Rezaei, 2011, Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy, Acta Medica Iranica, 49, 701
  15. Rodriguez, 1989, Severe preeclamsia. Nifedipine versus chlorpromazine in the management of the acute hypertensive state, Revista Medica Instituto Mexicano del Seguro Social, 27, 359
  16. Walss Rodriguez, 1993, Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive drugs, Ginecologia y Obstetricia de Mexico, 61, 76
  17. Vargas, 1998, Efficacy of isosorbide in aerosol form in the management of hypertensive crisis in severe preeclampsia, Ginecologia y Obstetricia de Mexico, 66, 316
  18. Bolte, 1995, Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe early onset pre-eclampsia, American Journal of Obstetrics and Gynecology, 172, 384, 10.1016/0002-9378(95)91140-5 · doi:10.1016/0002-9378(95)91140-5
  19. Bolte AC Dekker GA van Eyck J Bruinse HW Kanhai HH de Vries A Ketanserin versus dihydralazine in the treatment of early onset pre-eclampsia Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 148
  20. Bolte AC Dekker GA van Eyck J Bruinse HW Kanhai HH de Vries A Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe early onset preeclampsia Proceedings of the International Society for the Study of Hypertension in Pregnancy, European Branch; 1995 July 20-22; Leuven Belgium 1995 18
  21. Bolte AC Dekker GA van Eyck J Strack van Schijndel RJM de Vries A van Geijn HP Comparison of the effectivity and safety of ketanserin vs dihydralazine in the treatment of severe pre-eclampsia Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia 1994 42
  22. Bolte, 1998, The haemodynamic effects of ketanserin versus dihydralazine in severe early onset hypertension in pregnancy, British Journal of Obstetrics and Gynaecology, 105, 723, 10.1111/j.1471-0528.1998.tb10202.x · doi:10.1111/j.1471-0528.1998.tb10202.x
  23. Bolte, 2001, Use of ketanserin in hypertensive disorders of pregnancy [abstract], American Journal of Obstetrics and Gynecology, 185, S171, 10.1016/S0002-9378(01)80357-4 · doi:10.1016/s0002-9378(01)80357-4
  24. Bolte, 2002, Ketanserin, a serotonin2 receptor blocker, for hypertension in pregnancy, Hypertension in Pregnancy, 21, 9
  25. Bolte, 2003, Ketanserin for hypertension in pregnancy, Australian and New Zealand Journal of Obstetrics and Gynaecology, 43, 179
  26. Belfort, 1998, Interim report of the nimodipine vs. magnesium sulfate for seizure prophylaxis in severe preeclampsia study: an international, randomized controlled trial, American Journal of Obstetrics and Gynecology, 178, S7
  27. Belfort, 1998, Change in estimated cerebral perfusion pressure following nimodipine or magnesium sulfate in patients with severe preeclampsia, American Journal of Obstetrics and Gynecology, 178, S114
  28. Belfort, 1999, Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia, American Journal of Obstetrics and Gynecology, 181, 402, 10.1016/S0002-9378(99)70569-7 · doi:10.1016/s0002-9378(99)70569-7
  29. Moodley J The use of nifedipine in acute hypertensive emergencies of pregnancy Proceedings of 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Canada 1988 141
  30. Howarth, 1997, A randomized controlled pilot study comparing urapidil to dihydralazine in the management of severe hypertension in pregnancy, Hypertension in Pregnancy, 16, 213, 10.3109/10641959709031638 · doi:10.3109/10641959709031638
  31. Pattinson RC Seris A Venter CP Howarth G Urapidil versus dihydralazine for control of severe hypertension in pregnancy: a pilot study Proceedings of the 12th Conference on Priorities in Perinatal Care; 1993; South Africa 1993 140 3
  32. Maharaj, 1997, A comparative study of intravenous isradipine and dihydralazine in the treatment of severe hypertension of pregnancy in black patients, Hypertension in Pregnancy, 16, 1, 10.3109/10641959709069085 · doi:10.3109/10641959709069085
  33. Maharaj B Moodley J Khedun SM Rapiti N van der Byl K Intravenous isradipine in the management of severe hypertension in pregnancy Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 131
  34. Maharaj B Moodley J Khedun SM Rapiti N van der Byl K Intravenous isradipine in the management of severe hypertension in pregnancy Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia 1994 158
  35. Steyn DW Odendaal HJ Dihydralazine or ketanserin for severe hypertension in pregnancy? Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia 1994 152
  36. Steyn, 1997, Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results, European Journal of Obstetrics & Gynecology and Reproductive Biology, 75, 155, 10.1016/S0301-2115(97)00123-1 · doi:10.1016/s0301-2115(97)00123-1
  37. Hall, 2000, Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial, Hypertension in Pregnancy, 19, 12
  38. Hall DR Odendaal HJ Steyn DW Smith M Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial Women's Health - into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3-6; Cape Town South Africa RCOG 1999 49
  39. Elatrous, 2002, Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol, Intensive Care Medicine, 28, 1281, 10.1007/s00134-002-1406-3 · doi:10.1007/s00134-002-1406-3
  40. Belfort M Taskin O Buhur A Saade G Yalcinoglu A Intravenous nimodipine in the management of severe preeclampsia: a double blind randomised controlled clinical trial Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 124
  41. Mabie WC Gonzalez-Ruiz A Amon E Sibai BM A comparative trial of labetolol and hydralazine for acute management of severe hypertension complicating pregnancy Proceedings of 5th International Congress, International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK 1987 91
  42. Adair, 2009, The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial, Journal of Perinatology, 29, 284, 10.1038/jp.2008.224 · doi:10.1038/jp.2008.224
  43. Adair, 2010, Digoxin Immune Fab treatment for severe preeclampsia; relationship between response and baseline endogenous digitalis-like factor, Pregnancy Hypertension, 1 Suppl 1, S21, 10.1016/S2210-7789(10)60093-1 · doi:10.1016/s2210-7789(10)60093-1
  44. Voto L Lapidus A Neira J Margulies M Atenolol versus alpha methyl dopa in the treatment of hypertension in pregnancy Proceedings of the 5th International Congress, International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK, 1986 1986 138
  45. Aslam, 2007, Pregnancy induced hypertension; anti-hypertensive therapy in a study using single drug versus multiple drugs, Professional Medical Journal, 14, 30, 10.29309/TPMJ/2007.14.01.3619 · doi:10.29309/tpmj/2007.14.01.3619
  46. Buddle ML Brown MA Farrell T Rapid treatment of severe hypertension in pregnancy 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology; 2001 September 5-7; Darwin, Australia 2001 118 · doi:10.1046/j.1440-1797.2002.00007-1-118.x
  47. Kahhale, 1985, Comparative study of chronic hypertensive pregnant women treated and non-treated with pindolol, Ginecologia e Obstetricia Brasileiras, 8, 85
  48. Bruno, 1988, Nifedipine versus hydralazine: randomized, placebo-controlled and double blind trial in severe hypertension complicating pregnancy, Revista do Hospital de Clinicas de Porto Alegre, 8, 75
  49. Atallah, 1990, A randomized controlled study of hydralazine and nifedipine in hypertensive crisis during pregnancy, Revista Brasileira de Ginecologia y Obstetricia, 12, 10
  50. Devi, 2012, Intravenous labetalol versus oral nifedipine in the treatment of severe hypertension in pregnancy, Kuwait Medical Journal, 44, 287
  51. Toppozada, 1989, Management of severe pre-eclampsia with prostaglandin A1: a useful therapeutic approach, Journal of Obstetrics and Gynaecology, 9, 184, 10.3109/01443618909151031 · doi:10.3109/01443618909151031
  52. Toppozada, 1992, Improving placental blood flow in pre-eclampsia with prostaglandin A1, Acta Obstetricia et Gynecologica Scandinavica, 71, 22, 10.3109/00016349209007942 · doi:10.3109/00016349209007942
  53. Esmaoglu, 2009, Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit, Journal of Critical Care, 24, 551, 10.1016/j.jcrc.2009.02.001 · doi:10.1016/j.jcrc.2009.02.001
  54. Kwawukume, 1995, Oral nifedipine therapy in the management of severe preeclampsia, International Journal of Gynecology & Obstetrics, 49, 265, 10.1016/0020-7292(95)02372-J · doi:10.1016/0020-7292(95)02372-j
  55. Graves, 2012, Deep trial secondary analysis: Digoxin immune fab fragment treatment has additional benefits in endogenous digitalis-like factor positive preeclamptic women, Pregnancy Hypertension, 2, 287, 10.1016/j.preghy.2012.04.198 · doi:10.1016/j.preghy.2012.04.198
  56. Hopate, 2008, In-vivo reversal of functional sodium pump inhibition with Digibind treatment, Hypertension in Pregnancy, 27, 460
  57. Daftary, 1963, A controlled clinical trial of guanethidine in toxemia of pregnancy, Indian Journal of Medical Sciences, 17, 812
  58. Samal, 2001, Management of eclampsia with magnesium sulphate and nifedipine, Journal of Obstetrics and Gynecology of India, 51, 71
  59. Ghahiri, 1994, The effect of nifedipin on the BP of the patients with severe preeclampsia, International Journal of Gynecology & Obstetrics, 46, 121
  60. Paternoster, 2004, Efficacy of AT in pre-eclampsia: a case control prospective trial, Thrombosis and Haemostasis, 91, 283, 10.1160/TH03-06-0388 · doi:10.1160/th03-06-0388
  61. Fletcher, 1999, An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia, Journal of Obstetrics and Gynaecology, 19, 235, 10.1080/01443619964977 · doi:10.1080/01443619964977
  62. Fletcher, 1996, An open trial comparing usual care (hydralazine) with injectable isradipine in severe pre-eclampsia [abstract], West Indian Medical Journal, 45, 27
  63. Kanayama, 1999, A new treatment of severe pre-eclampsia by long term epidural anaesthesia, Journal of Human Hypertension, 13, 167, 10.1038/sj.jhh.1000783 · doi:10.1038/sj.jhh.1000783
  64. Seki, 2002, Long-term treatment with nicardipine for severe pre-eclampsia, International Journal of Gynecology & Obstetrics, 76, 135, 10.1016/S0020-7292(01)00569-0 · doi:10.1016/s0020-7292(01)00569-0
  65. Lam, 2008, Antepartum administration of a digoxin immune fab (Digibind) improves renal function in patients with severe preeclampsia, Hypertension in Pregnancy, 27, 422
  66. Jegasothy, 1996, Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice, Journal of Obstetrics and Gynaecology Research, 22, 21, 10.1111/j.1447-0756.1996.tb00930.x · doi:10.1111/j.1447-0756.1996.tb00930.x
  67. Manzur-Verastegui, 2008, Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial, Clinical and Experimental Pharmacology and Physiology, 35, 580, 10.1111/j.1440-1681.2007.04838.x · doi:10.1111/j.1440-1681.2007.04838.x
  68. Pardo-Morales, 2004, New therapeutics alternative in severe preeclampsia, Cirugia y Cirujanos, 72, 203
  69. Roes, 2002, Oral n-acetylcysteine supplementation does not prolong pregnancy in women with severe preeclampsia: a randomised, placebo-controlled trial [abstract], Hypertension in Pregnancy, 21, 47
  70. Pogue, 2006, Removal of agonistic autoantibodies against the angiotensin AT receptor in patients with preeclampsia [abstract], Journal of the American Society of Nephrology, 17, 658A
  71. Ratnam, 1971, A comparison of hypotensive drugs in patients with hypertensive disorders in late pregnancy, Australian and New Zealand Journal of Obstetrics and Gynaecology, 11, 78, 10.1111/j.1479-828X.1971.tb00458.x · doi:10.1111/j.1479-828x.1971.tb00458.x
  72. Smith, 2005, Oral labetalol given to treated non hypertensive patients with preeclampsia is no more likely to cause hypotension than magnesium sulfate [abstract], American Journal of Obstetrics and Gynecology, 193, S78, 10.1016/j.ajog.2005.10.282 · doi:10.1016/j.ajog.2005.10.282
  73. Sankar, 1984, Low-dose diazoxide in the emergency management of severe hypertension in pregnancy, South African Medical Journal, 65, 279
  74. Bhorat, 1993, Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine, American Journal of Obstetrics and Gynecology, 168, 1292, 10.1016/0002-9378(93)90383-T · doi:10.1016/0002-9378(93)90383-t
  75. Bhorat IE Naidoo DP Rout CC Moodley J Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 march 15-18; Sydney, Australia 1994 162
  76. Schie, 2002, The optimal dosage of ketanserin for pateints with severe hypertension in pregnancy, European Journal Obstetrics & Gynecology and Reproductive Biology, 102, 161, 10.1016/S0301-2115(01)00611-X · DOI
  77. Cararach V Torres Pons PJ Roca M Codina C Cobo E Gonzalez-Merlo J Treatment of severe hypertension in pregnancy. Double blind controlled trial a treatment pattern (TP) with hydralazine + methyldopa a single TP with labetolol Proceedings of 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Canada 1988 101
  78. Steyn DW Hall DR Odendaal H The optimal dosage of nifedipine in patients with early onset severe pre-eclampsia - a randomised controlled trial 22nd Conference on Priorities in Perinatal Care in South Africa; 2003 March 11-14; Free State, South Africa 2003
  79. Hjertberg R Faxelius G Lagercrantz H Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland 1994 18
  80. Scardo, 1999, Randomized double blinded hemodynamic study of oral nifedipine and IV labetolol in hypertensive urgencies of pregnancy, American Journal of Obstetrics and Gynecology, 180, S18
  81. Vermillion, 1999, A prospective randomized double blind trial of oral nifedipine and intravenous labetolol in hypertensive emergencies, American Journal of Obstetrics and Gynecology, 180, S14
  82. Reyna-Villasmil, 2001, Effect of transdermal nitroglycerin on umbilical artery blood flow in preeclampsia [abstract], Journal of Perinatal Medicine, 29 Suppl 1, 486
  83. Waheed, 2005, Comparison of intravenous hydralazine-bolus dose versus continuous infusion drip in eclampsia, Annals of King Edward Medical College, 11, 521
  84. Warren, 2004, First interim report on the labetalol versus magnesium sulfate for the prevention of eclampsia trial (LAMPET) [abstract], Hypertension in Pregnancy, 23, 9
  85. Mesquita, 1995, The use of hydralazine and nifedipine in hypertensive emergencies in pregnancy, Revista Brasileira de Ginecologia e Obstetricia, 17, 103
  86. Clarke M Oxman AD Cochrane Reviewers’ Handbook 4.1.5 [updated April 2002] In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated quarterly
  87. Hennessy, 2007, A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial, Australian and New Zealand Journal of Obstetrics and Gynaecology, 47, 279, 10.1111/j.1479-828X.2007.00738.x · DOI
  88. The Cochrane Collaboration Review Manager (RevMan) 2000
  89. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011
  90. Duley L IV labetalol vs iv diazoxide in severe pre-eclampsia In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995
  91. Duley L Labetalol vs hydralazine in severe pregnancy-induced hypertension In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995
  92. Duley L Nifedipine vs hydralazine in severe pregnancy-induced hypertension In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995
  93. Duley L Prostacyclin vs dihydralazine in severe hypertension In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995
  94. Duley, 1999, Drugs for rapid treatment of very high blood pressure during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001449 · doi:10.1002/14651858.cd001449
  95. Duley, 2002, Drugs for rapid treatment of very high blood pressure during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001449 · doi:10.1002/14651858.cd001449

Cited by

Metadata

Authors
Duley, L., Meher, S., & Jones, L.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2013-07-31
Volume
2013
Issue
7
Pages
CD001449-CD001449
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W1693011515
Cited by
423
References
72
FWCI
37.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.